Nuran Chaban

Affiliations
  • Marketing Department, mAbxience research S.L, Madrid, 28050, Spain.

Publications (1)

Current state and comparison of the clinical development of bevacizumab, rituximab and trastuzumab biosimilars.

Future oncology (London, England)
Avec: Luis Pérez Díaz , Susana Millán , Nuran Chaban , Ana Del Campo , Eduardo Spitzer

Réseau de co-auteurs

Luis Pérez Díaz 1 collaboration
Susana Millán 1 collaboration
Ana Del Campo 1 collaboration
Eduardo Spitzer 1 collaboration